WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (WINT) Stock Price, Quote, News & History

WINTOTCEM
$0.1100
At close: Aug 29, 5:00 PM EST

WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (WINT) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-15.12M
Investing Cash Flow (TTM)
-5.97M
Financing Cash Flow (TTM)
19.00M
Free Cash Flow (TTM)
-15.12M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-2.10M

Analyst Rating and Forecast

12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$12.73M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.34

Company Debt

Total Debt
$12.14M
LT Debt
-
LT Debt Issuance (TTM)
$1.31M
LT Debt Repayment (TTM)
-$2.00M
Total Cash
$204.00K
Debt to Equity
-
Issuance of Debt (TTM)
-$688.00K
Repayment of Debt (TTM)
-$3.12M

Key Statistics

Open
-
Close
-
Volume / Avg.
2.05K / 59.20K
Day Range
- - -
52 Wk Range
0.00 - 0.19
Market Cap
-
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticul...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (WINT) stock?

A

You can purchase shares of WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (OTCEM:WINT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (WINT) competitors?

A

There are no as such competitors for WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc..

Q

What is the forecast, or price target, for WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (WINT) stock?

A

WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. has a consensus price target of $350.00.

Q

What is the current price for WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (WINT)?

A

The stock price for WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (OTCEM: WINT) is $0.0003 last updated September 18, 2026 at 1:01 PM EDT.

Q

Does WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (WINT) pay a dividend?

A

There are no upcoming dividends for WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc..

Q

When is WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (OTCEM:WINT) reporting earnings?

A

WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. does not have any upcoming earnings scheduled.

Q

Is WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (WINT) going to split?

A

There is no upcoming split for WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc..

Q

What sector and industry does WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. (WINT) operate in?

A

WINDTREE THERAPEUTICS NEW by Windtree Therapeutics, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.